These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial. Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW; Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813 [TBL] [Abstract][Full Text] [Related]
18. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial. Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY; Trials; 2013 Oct; 14():317. PubMed ID: 24083670 [TBL] [Abstract][Full Text] [Related]
19. Final Results of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial. de Celis-Ruiz E; Fuentes B; Alonso de Leciñana M; Gutiérrez-Fernández M; Borobia AM; Gutiérrez-Zúñiga R; Ruiz-Ares G; Otero-Ortega L; Laso-García F; Gómez-de Frutos MC; Díez-Tejedor E Cell Transplant; 2022; 31():9636897221083863. PubMed ID: 35301883 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Ringelstein EB; Thijs V; Norrving B; Chamorro A; Aichner F; Grond M; Saver J; Laage R; Schneider A; Rathgeb F; Vogt G; Charissé G; Fiebach JB; Schwab S; Schäbitz WR; Kollmar R; Fisher M; Brozman M; Skoloudik D; Gruber F; Serena Leal J; Veltkamp R; Köhrmann M; Berrouschot J; Stroke; 2013 Oct; 44(10):2681-7. PubMed ID: 23963331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]